vTv Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $17 | $0 |
Gross Profit | -3 | -9 | -5 | -22 |
EBITDA | -7,377 | -6,208 | -4,415 | -5,818 |
EBIT | -7,380 | -6,217 | -4,437 | -5,840 |
Net Income | -6,046 | -5,092 | -3,634 | -4,783 |
Net Change In Cash | 0 | 0 | 17 | 0 |
Free Cash Flow | -5,095 | -5,687 | -4,825 | -6,418 |
Cash | 25,922 | 31,059 | 36,746 | 41,571 |
Basic Shares | 6,587 | 6,582 | 5,771 | 5,456 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,017 | $9 | $2,018 | $4,005 |
Gross Profit | 928 | -90 | 1,926 | 3,916 |
EBITDA | -22,516 | -25,863 | -24,766 | -17,515 |
EBIT | -22,605 | -25,953 | -24,858 | -17,604 |
Net Income | -18,462 | -20,250 | -19,164 | -12,987 |
Net Change In Cash | 1,017 | 9 | 2,018 | 4,005 |
Cost of Revenue | -1,289 | |||
Free Cash Flow | -25,307 | -19,081 | -16,043 | -19,308 |
Cash | 36,746 | 9,446 | 12,126 | 13,415 |
Basic Shares | 5,771 | 2,084 | 1,919 | 1,566 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.92 |
2025-03-31 | -$0.77 |
2024-12-31 | -$0.55 |
2024-09-30 | -$0.87 |
